BIOENGR M233A
Medtech Innovation I: Entrepreneurial Opportunities in Medical Technology
Grades
3.92
Average grade awarded in BIOENGR M233A. Not a student rating: this is what the grades were.
In the A range
98%
of the 138 letter grades
D, F or W
0.0%
of every letter grade awarded, plus withdrawals
Taken pass/no pass
0%
nobody in the record took it pass/no pass
The registrar's own records: 138 grades over 3 terms, Fall 2021 to Fall 2025. Every instructor is pooled here.
What is inside that record
No summer session is in that record.
The table below splits them, and term averages across those 3 terms ran 3.87 to 3.99.
Historical grades for all professors, across recorded terms. The course summary above includes all professors.
- A+ 18 · 13.0%
- A 86 · 62.3%
- A- 31 · 22.5%
- B+ 3 · 2.2%
Percentages are of the 138 letter grades. Grey bars are non-letter outcomes.
How the non-letter outcomes are counted
They are excluded from the GPA entirely rather than scored, because counting a P as a 4.0 would be a fabrication.
By instructor
| Instructor | Predicted GPA | Raw | n | Terms | A range | Workload | Spring 2026 |
|---|---|---|---|---|---|---|---|
| LIU, WENTAI reviews ↗ | 3.91 | 3.92 | 138 | 3 | 98% | - | not teaching it |
| TSENG, HSIAN-RONG reviews ↗ | 3.89 | 3.89 | 94 | 2 | 97% | - | not teaching it |
Why Predicted is not the Raw average
“Predicted” is shrunk toward the course average, which is itself shrunk toward the department, so an instructor with a handful of students sits near the course mean rather than topping the list.
Grade records describe outcomes. For what a course is like to take, read student reviews written on dibs below or follow the separate external review link.
Workload and assignments
Work types reported in BruinWalk reviews of this course, across recorded instructors and terms. They may differ from this term's syllabus.
dibs has not read this course’s reviews, so it cannot say what kind of work it sets. That is dibs not having looked. It is not a course without papers or exams, and the reviews linked below are the answer until dibs catches up.
What comes first
dibs has not read a class page for BIOENGR M233A in any term it holds, so it cannot say what comes before it.
Counted in courses rather than quarters: dibs does not know which of them a department lets you take together.
In Springs
Has not run in Spring in the 3 Springs dibs holds records for, back to Winter 2023. That is 3 years of grade records rather than the course catalog, so it says what has happened and not what the department will do next.
From the terms dibs holds, which start in Fall 2021 and exclude summer. A department can run a course in a quarter it never has before.
From the registrar's catalog
(Same as Management M271A.) Lecture, three hours; outside study, nine hours. Designed for graduate and professional students in engineering, dentistry, design, law, management, and medicine. Focus on understanding how to identify unmet clinical needs, properly filtering through these needs using various acceptance criteria, and selecting promising needs for which potential medtech solutions are explored. Students work in groups to expedite traditional research and development processes to invent and implement new medtech devices that increase quality of clinical care and result in improved patient outcomes in hospital system. Introduction to intellectual property basics and various medtech business models. Letter grading.
Sections in Spring 2026
From the people who took it
Student reviews
What taking BIOENGR M233A was like: the work, the teaching, and what students wish they’d known.
Your experience could be the first.
No student reviews are available to read on dibs for this course yet. Took it? Tell the next person what helped, what was hard, and how you spent your time.
Looking for more perspectives?
External reviews are separate and do not count toward the dibs rating.